Skip to content
Pharma Observatory a Scientist.com platform
  • Supplier site
  • Group of sites (click to zoom)

Scientist.com supplier network (site locations)

Research supplier

Igenica

Igenica is listed as a small business research supplier in the Scientist.com network, with 1 site in 1 country and 1 service area.

View Igenica on Scientist.com

Sign in to Scientist.com to open this supplier in your organization's marketplace.

Email me this page as a PDF

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 1
Countries 1

Services

What this research supplier says it provides, as listed in the Scientist.com network.

Type of company: Small business

Biology

Source: Scientist.com supplier network

Where it operates

Sites by country, with the cities in each.

  • United States Burlingame 1 site

Source: Scientist.com supplier network (site locations)

About this supplier

In the supplier's own words, as listed in the Scientist.com network.

Igenica's foundational vision was to build a biopharmaceutical company with a complete suite of technologies supporting the discovery of antibody-based therapeutics. These technologies span from target discovery to antiboby discovery and differentiation site-specific antibody-drug conjugate (ADC) technologies. Igencia has effectively integrated these technologies to combine the optimal molecular targets, monclonal antibodies and drug modalities to enable pipeline of first-in-class product candidates in multiple indications. Igenica's three core technology platforms include: sTAg - fresh...

Show the full description

Igenica's foundational vision was to build a biopharmaceutical company with a complete suite of technologies supporting the discovery of antibody-based therapeutics.
These technologies span from target discovery to antiboby discovery and differentiation site-specific antibody-drug conjugate (ADC) technologies. Igencia has effectively integrated these technologies to combine the optimal molecular targets, monclonal antibodies and drug modalities to enable pipeline of first-in-class product candidates in multiple indications.
Igenica's three core technology platforms include:
sTAg - fresh primary tumors,focus on surface proteome
iTAb - harnesses tumor microenviroment,mAb discobery for multi-spanners,early in vvo readout
SNAP - antibody-drug conjugates,homogeneous ADCs,uses existing mAbs without need for mutagenesis

Website
www.igenica.com

Source: Scientist.com supplier network, written by the supplier

Get the Igenica report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Sources: Scientist.com supplier network.

Work with Igenica on Scientist.com

For prices, more details, or to contact Igenica, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.